Every record from Janoshik · page 39
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020129 | Retatrutide | GGPeps | GGPE-2508-E8992 | 2025-Q3 | 97.97 | 2.40 | 105.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020023 | Ipamorelin | ERP | ERP-2502-S7254 | 2025-Q3 | 99.01 | 3.74 | 97.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019419 | Semaglutide | Homopeptide | HOMO-2505-V8950 | 2025-Q3 | 98.86 | 6.64 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018885 | Retatrutide | QSC | QSC-2504-R9199 | 2025-Q3 | 99.34 | 2.36 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018795 | AOD-9604 | QSC | QSC-2508-B8479 | 2025-Q3 | 99.40 | 3.64 | 89.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018670 | MK-677 (Ibutamoren mesylate) | QYB | QYB-2503-W6005 | 2025-Q3 | 98.73 | 4.32 | 98.0 | Supplier-supplied | 2 | FAIL |
| AX-2025-020993 | Enclomiphene citrate | CPC | CPC-2505-Y3713 | 2025-Q3 | 99.32 | 6.52 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020265 | BPC-157 | MKM | MKM-2502-T2878 | 2025-Q3 | 99.30 | 6.23 | 101.1 | Supplier-supplied | 0 | PASS |
| AX-2025-020248 | BPC-157 | GGPeps | GGPE-2502-U2458 | 2025-Q3 | 99.06 | 4.62 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019560 | Semaglutide | Homopeptide | HOMO-2506-M1846 | 2025-Q3 | 99.45 | 5.89 | 89.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019383 | Gonadorelin | TFC | TFC-2503-A8165 | 2025-Q3 | 99.18 | 4.42 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019349 | MOTS-c | TFC | TFC-2505-V7070 | 2025-Q3 | 98.71 | 3.08 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019312 | MOTS-c | TFC | TFC-2503-C7376 | 2025-Q3 | 99.37 | 5.56 | 93.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018881 | Retatrutide | QSC | QSC-2504-R9199 | 2025-Q3 | 98.89 | 1.96 | 95.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020414 | Melanotan II | KP | KP-2508-J4716 | 2025-Q3 | 97.61 | 6.52 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-020354 | Liraglutide | MKM | MKM-2508-P3929 | 2025-Q3 | 97.96 | 6.08 | 90.0 | Supplier-supplied | 0 | PASS |
| AX-2025-020119 | Tirzepatide | GGPeps | GGPE-2502-J8885 | 2025-Q3 | 97.80 | 5.50 | 95.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019726 | PEG-MGF | HJ | HJ-2507-S2872 | 2025-Q3 | 98.14 | 7.14 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019427 | Semaglutide | Homopeptide | HOMO-2505-V8950 | 2025-Q3 | 98.64 | 5.35 | 92.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020708 | GHK-Cu | GL Biochem | GLBI-2502-L8987 | 2025-Q3 | 97.59 | 3.94 | 104.2 | Supplier-supplied | 2 | FAIL |
| AX-2025-020707 | GHK-Cu | GL Biochem | GLBI-2502-L8987 | 2025-Q3 | 96.68 | 4.27 | 102.4 | Buyer-sourced | 1 | FAIL |
| AX-2025-020706 | GHK-Cu | GL Biochem | GLBI-2502-L8987 | 2025-Q3 | 96.80 | 3.46 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-020112 | Tirzepatide | GGPeps | GGPE-2502-J8885 | 2025-Q3 | 97.86 | 6.24 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019470 | Retatrutide | Homopeptide | HOMO-2508-U9007 | 2025-Q3 | 98.71 | 6.37 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018859 | Desmopressin | QSC | QSC-2505-N8999 | 2025-Q3 | 99.93 | 4.31 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018857 | Desmopressin | QSC | QSC-2505-N8999 | 2025-Q3 | 99.52 | 4.30 | — | Supplier-supplied | 0 | PASS |
| AX-2025-021240 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | 2025-Q3 | 97.43 | 6.41 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-020905 | Semaglutide | CPC | CPC-2504-G2724 | 2025-Q3 | 97.88 | 5.11 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020424 | Melanotan II | KP | KP-2508-J4716 | 2025-Q3 | 98.36 | 6.47 | 90.8 | Supplier-supplied | 1 | FAIL |
| AX-2025-020362 | Liraglutide | MKM | MKM-2508-P3929 | 2025-Q3 | 98.16 | 7.03 | 101.8 | Supplier-supplied | 0 | PASS |
| AX-2025-019990 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 98.69 | 3.19 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019906 | Thymosin α1 | SWB | SWB-2503-S5672 | 2025-Q3 | 99.71 | 3.18 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019014 | MOTS-c | JEEP | JEEP-2507-W2442 | 2025-Q3 | 99.76 | 4.56 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018874 | TB-500 | QSC | QSC-2505-B8934 | 2025-Q3 | 99.35 | 4.59 | 94.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020670 | SS-31 (Elamipretide) | GL Biochem | GLBI-2507-R8450 | 2025-Q3 | 98.23 | 3.48 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020601 | Semaglutide | SSA | SSA-2508-Y6894 | 2025-Q3 | 98.81 | 4.90 | 100.9 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020559 | Semaglutide | SSA | SSA-2502-U6796 | 2025-Q3 | 98.16 | 5.43 | 94.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020385 | MGF | MKM | MKM-2508-S3601 | 2025-Q3 | 98.50 | 3.67 | 98.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019909 | Thymosin α1 | SWB | SWB-2503-S5672 | 2025-Q3 | 99.24 | 3.04 | 102.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019600 | TB-500 | Homopeptide | HOMO-2504-G1782 | 2025-Q3 | 99.23 | 4.86 | — | Supplier-supplied | 2 | MARGINAL |